Extravasation vs. Infiltration, and Vesicant Agents: Understanding the Particulars Involved to Avoid Coding Inaccuracies

It is important for coders and all healthcare professionals to know the difference, and why it matters.

Intravenous therapy (IV) is quite common, administered by healthcare professionals on a very regular basis. As common as it may be, however, it’s linked to an unusually high risk of potential harm to the patient. If a complication occurs, a patient could develop a severe wound, lose function of a limb, or even suffer amputation. Understanding the difference between infiltration and extravasation is essential for healthcare professionals, and just as significant for coders.

What is the difference between infiltration and extravasation?

Whether infiltration or extravasation, both involve an IV solution or medication getting into the tissue surrounding the vein. It is the type of solution or medication that is inadvertently delivered into the surrounding tissue that determines the difference.

Infiltration is the unintentional administration of a non-vesicant medication into surrounding cell tissue. This is a relatively common and generally minor occurrence. Infiltration does not usually cause harm, but the medicine or solution may cause redness, swelling, and discomfort around the site.

Extravasation refers to the unintentional administration of a vesicant medication into the surrounding tissue. These are active chemical substances that can cause blistering, and in extreme cases, necrosis. It is not uncommon for a patient to receive a local injection of a reversal agent if extravasation occurs. If left untreated, the patient may have to have debridement or skin grafting, or he or she could suffer disfigurement, loss of function, and even amputation. 

It is important to note that infiltration and extravasation can exist at the same time. Doctors often use infiltration and extravasation interchangeably. Both are caused when the vein leaks or the IV catheter comes out of the vein; however, extravasation is far more severe. Again, the essential difference between infiltration and extravasation is the type of medicine or fluid that is leaked. Extravasation is much more severe than infiltration due to vesicant agents within an IV solution.

Vesicant Agents

It is important to know if the substance that got into the tissue is a vesicant agent. Vesicants and non-vesicants are the two classes of IV solutions. In both IV solutions and medications, however, vesicant agents are highly reactive chemicals that cause cellular-level changes, resulting in serious or even life-threatening complications.

For coders, when determining if there is a code-able occurrence, the agent that has infiltrated must be taken into account. Further considerations include this question: was it treated, or did it impact the stay?

Coders must identify vesicant agents. Some common examples of vesicant medications and fluids include vancomycin, potassium chloride, calcium gluconate, dopamine, and Dilantin. This type of data may not always be easily accessible. If the coder is in doubt, they must take it one step further – utilize Internet resources, contact a supervisor, or leverage the expertise of a clinical documentation improvement (CDI) colleague. Information can be accessed through the utilization of resources. It is important to leverage all available resources to obtain a true and accurate diagnosis.

Accurate coding and documentation of infiltration and extravasation requires a complete understanding of the difference between the two, and may warrant a more comprehensive examination. For coders, additional efforts may be required to ensure accuracy, in consideration of the many areas that are dependent upon the codes, such as the reputation and quality of the organization, as well as research, and certainly reimbursement.

In keeping up with the expanding complexities of coding and the direct effect codes have on diagnosis assignment, more than ever before, coders must utilize critical thinking skills and all available resources.

Programming Note: Listen to Susan Gatehouse report this story live during Talk Ten Tuesdays today, 10-10:30 a.m. EST.

Facebook
Twitter
LinkedIn

Susan Gatehouse, RHIT, CCS,CPC, AHIMA-Approved ICD-10-CM/PCS Trainer

Susan Gatehouse is the founder and chief executive officer of Axea Solutions. An industry expert in revenue cycle management, Gatehouse established Axea Solutions in 1998, and currently partners with healthcare organizations across the nation, to craft solutions for unique challenges in the dynamic world of healthcare reimbursement and data management.

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24